An implant for sleep apnea is one of the few CPAP alternatives. This article compares hypoglossal nerve stimulation and ...

Inspire Medical shares dipped — but have since mostly recovered — following news of a government investigation following Q4 ...

MINNEAPOLIS, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, ...

minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology ...

If you meet FDA indications for Inspire therapy and are below the requisite body mass index, your insurance company is very likely to pay for all or most of the Inspire Sleep Apnea cost. The treatment ...

minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology ...

Inspire Medical Systems (NYSE:INSP – Free Report) had its price target trimmed by Morgan Stanley from $230.00 to $220.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm ...

Inspire Medical Systems (NYSE:INSP – Get Free Report) had its price objective lowered by Truist Financial from $250.00 to $235.00 in a note issued to investors on Tuesday,Benzinga reports. The ...

The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted to grow at a robust CAGR of 10.1%, reaching US$ 878.9 Million in 2024 and an impressive US$ 1,5 ...